Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Chromadex Corp CS (CDXC)

Chromadex Corp CS (CDXC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 443,280
  • Shares Outstanding, K 68,197
  • Annual Sales, $ 59,260 K
  • Annual Income, $ -19,930 K
  • 60-Month Beta 1.64
  • Price/Sales 7.79
  • Price/Cash Flow N/A
  • Price/Book 13.04
Trade CDXC with:

Options Overview

Details
  • Implied Volatility 94.55%
  • Historical Volatility 49.88%
  • IV Percentile 40%
  • IV Rank 17.52%
  • IV High 302.83% on 02/26/21
  • IV Low 50.31% on 01/07/21
  • Put/Call Vol Ratio 0.75
  • Today's Volume 70
  • Volume Avg (30-Day) 280
  • Put/Call OI Ratio 0.89
  • Today's Open Interest 3,025
  • Open Int (30-Day) 2,311

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.10
  • Number of Estimates 3
  • High Estimate -0.08
  • Low Estimate -0.11
  • Prior Year -0.07
  • Growth Rate Est. (year over year) -42.86%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.15 +29.90%
on 09/15/21
8.75 -23.54%
on 09/01/21
-1.39 (-17.20%)
since 08/20/21
3-Month
5.15 +29.90%
on 09/15/21
10.78 -37.94%
on 06/28/21
-2.30 (-25.58%)
since 06/21/21
52-Week
3.82 +75.13%
on 10/02/20
23.66 -71.72%
on 02/25/21
+2.52 (+60.43%)
since 09/21/20

Most Recent Stories

More News
ChromaDex Shares Preclinical Research Findings and Scientific Initiations from the ChromaDex External Research Program (CERP(TM))

ChromaDex Corp. (NASDAQ:CDXC) today announced findings from recently published preclinical studies, as well as recently registered clinical research, investigating Niagen(R) (patented nicotinamide riboside,...

CDXC : 6.68 (+2.77%)
ChromaDex Continues to Defend Strong Intellectual Property Portfolio and Plans to Appeal Judge's Ruling in Patent Infringement Lawsuit

ChromaDex Corp. (NASDAQ:CDXC) issued the following statement:

CDXC : 6.68 (+2.77%)
ChromaDex (CDXC) Reports Q2 Loss, Tops Revenue Estimates

ChromaDex (CDXC) delivered earnings and revenue surprises of 11.11% and 7.14%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

CDXC : 6.68 (+2.77%)
ChromaDex Corporation Reports Second Quarter 2021 Financial Results

ChromaDex Corp. (NASDAQ:CDXC) today announced financial results for the second quarter of 2021.

CDXC : 6.68 (+2.77%)
ChromaDex to Report Second Quarter 2021 Financial Results on Tuesday, August 3, 2021

ChromaDex Corp. (NASDAQ:CDXC) announced that it will hold a conference call on Tues., August 3, 2021 at 4:30 p.m. ET to discuss its financial results for the second quarter ended June 30, 2021. The financial...

CDXC : 6.68 (+2.77%)
ChromaDex Shares Research Findings from the ChromaDex External Research Program (CERP(TM))

ChromaDex Corp. (NASDAQ:CDXC) today announced the results of four recently published preclinical studies, highlighting new findings for its patented nicotinamide riboside (NR) healthy aging nutrient.

CDXC : 6.68 (+2.77%)
ChromaDex and Walmart Launch Tru Niagen(R) in 3,800 Walmart Stores Across the United States

ChromaDex Corp. (NASDAQ:CDXC) announced today the launch of its flagship consumer product Tru Niagen(R) in Walmart, available in 3,800 stores across the United States. Walmart is the first major U.S. retailer...

CDXC : 6.68 (+2.77%)
ChromaDex (CDXC) Reports Q1 Loss, Misses Revenue Estimates

ChromaDex (CDXC) delivered earnings and revenue surprises of -33.33% and -10.87%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

CDXC : 6.68 (+2.77%)
ChromaDex Corporation Reports First Quarter 2021 Financial Results

ChromaDex Corp. (NASDAQ:CDXC) today reported first quarter 2021 financial results.

CDXC : 6.68 (+2.77%)
Chromadex Corp. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 6, 2021 / Chromadex Corp. (NASDAQ:CDXC) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 6, 2021 at 4:30 PM Eastern...

CDXC : 6.68 (+2.77%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

ChromaDex Corporation and its subsidiaries supply phytochemical reference standards and reference materials, related contract services, and products for the dietary supplement, nutraceutical, food and beverage, functional food, pharmaceutical and cosmetic markets. ChromaDex's core business strategy is...

See More

Key Turning Points

3rd Resistance Point 7.20
2nd Resistance Point 7.00
1st Resistance Point 6.75
Last Price 6.68
1st Support Level 6.31
2nd Support Level 6.11
3rd Support Level 5.86

See More

52-Week High 23.66
Fibonacci 61.8% 16.08
Fibonacci 50% 13.74
Fibonacci 38.2% 11.40
Last Price 6.68
52-Week Low 3.82

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar